MrSmith18
14 minutes ago
The long-awaited PR has finally arrived, and it was pretty straightforward. GS's S-1 filing under the 1940 Act may see "changes" in 2025, with the key adjustments likely being internal.
My take? Ligand seems to be approaching significant approvals in Q2, while SRNW's warrants could